Cargando…
Intranasal Mesenchymal Stem Cell Treatment for Neonatal Brain Damage: Long-Term Cognitive and Sensorimotor Improvement
Mesenchymal stem cell (MSC) administration via the intranasal route could become an effective therapy to treat neonatal hypoxic-ischemic (HI) brain damage. We analyzed long-term effects of intranasal MSC treatment on lesion size, sensorimotor and cognitive behavior, and determined the therapeutic wi...
Autores principales: | Donega, Vanessa, van Velthoven, Cindy T. J., Nijboer, Cora H., van Bel, Frank, Kas, Martien J. H., Kavelaars, Annemieke, Heijnen, Cobi J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536775/ https://www.ncbi.nlm.nih.gov/pubmed/23300948 http://dx.doi.org/10.1371/journal.pone.0051253 |
Ejemplares similares
-
Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse
por: Donega, Vanessa, et al.
Publicado: (2015) -
Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions
por: Donega, Vanessa, et al.
Publicado: (2014) -
The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies
por: Kooijman, Elke, et al.
Publicado: (2014) -
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
por: Zhou, Wenjun, et al.
Publicado: (2016) -
Long-Term Functional Consequences and Ongoing Cerebral Inflammation after Subarachnoid Hemorrhage in the Rat
por: Kooijman, Elke, et al.
Publicado: (2014)